A Study of Semorinemab in Patients With Moderate Alzheimer's Disease
Clinical trial NCT03828747 · COMPLETED
Trial details
- NCT number
- NCT03828747
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2021-07-20
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.